Abiopharma

🔍 ROHDE STEPHEN L (Executive)

Company: Slide Insurance Holdings, Inc. (SLDE)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Stock at $1.38 per share (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: false | shares_owned_after: 5,000.00 | transaction_form_type: 4
• Sold 5,000 shares of Common Stock at $21.0 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
• Sold 5,000 shares of Stock Option (Right to Buy) at $1.38 per share (Derivative)
  Date: 2026-08-06 | Code: M | Expires: 2033-07-12 | equity_swap_involved: false | shares_owned_after: 47,500.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $21.00 to $21.04 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
• F2: These stock options are fully vested and exercisable.